Everardo Cobos is an Oncology physician affiliated with The University of Texas Rio Grande Valley. OpenAlex indexes 271 publications with 3,495 citations (h-index 34).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2902 Haine Dr
Harlingen, TX 785508969
Telephone
956-296-4000Provider last certified this registry record 17 Jul 2024.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Neurocrine BioSciences, Inc.Program year20251 payment
- Carl Zeiss Meditec USA, Inc.Program year20251 payment
- Genentech USA, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
100%Hemoglobin S Polymerization Inhibitor100%Oxbryta100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Rio Grande Valley Cancer Health Disparity Research Center
University of Texas Rio Grande Valley
FY2026$3,659,138U54MD019970 - Rio Grande Valley Cancer Health Disparity Research Center
University of Texas Rio Grande Valley
FY2026$381,190U54MD019970 - Rio Grande Valley Cancer Health Disparity Research Center
University of Texas Rio Grande Valley
FY2025$3,712,690U54MD019970
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors
Cancer Chemotherapy and Pharmacology
2021 - Chimeric Antigen Receptor Engineering: A Right Step in the Evolution of Adoptive Cellular Immunotherapy
International Reviews of Immunology
2015 - Sex-Driven Differences in Immunological Responses: Challenges and Opportunities for the Immunotherapies of the Third Millennium
International Reviews of Immunology
2015 - Cancer-Testis Antigens and Immunotherapy in the Light of Cancer Complexity
International Reviews of Immunology
2015 - Treatment of Hepatic Epithelioid Hemangioendothelioma: Finding Uses for Thalidomide in a New Era of Medicine
Case Reports in Gastrointestinal Medicine
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Ihsan Salloum, MD
The University of Texas Rio Grande Valley
Ameer Hassan, DO
The University of Texas Rio Grande Valley
Wondwossen Tekle, MD
The University of Texas Rio Grande Valley
Perry Fuchs, MD
The University of Texas Rio Grande Valley
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”